The company operates on a robots-as-a-service (RaaS) model, allowing businesses to lease or purchase their AMRs.

Ati Motors' robots are specifically designed to automate dull, dirty, and dangerous tasks in manufacturing, addressing performance gaps compared to human workers.

This funding, raised on January 22, 2025, aims to support the company's global expansion plans and enhance product development.

The investment will particularly focus on expanding operations in North America and the Asia-Pacific region, including a new establishment in Mexico and an expansion of its headquarters in Detroit, Michigan.

Ati Motors specializes in AI and autonomous robotics for the industrial sector, deploying hundreds of its Sherpa robots across 40 manufacturers, including notable clients like Forvia and Hyundai.

Walden Catalyst Ventures has expressed confidence in Ati Motors' potential to lead the next wave of industrial automation due to its advanced AI and robotics capabilities.

The investment follows a strong performance for Ati Motors, which saw its order book triple in the fourth quarter of 2024 and acquired nine new industry clients.

Ati Motors, an autonomous mobile robots (AMR) startup based in India, recently announced a $20 million Series B funding round led by Walden Catalyst Ventures and NGP Capital, with participation from True Ventures, Exfinity Venture Partners, Athera Venture Partners, and Blume Ventures.

Key customers include major players such as Airbus, Ceat Tyres, Samsung, and TVS Motor, with 80% of their customer base in the automobile sector.

To date, Ati Motors has raised over $37 million and serves global leaders across various sectors, offering products like Tugs, Bin Movers, and Pallet Movers.

The startup designs all its software and hardware in-house, utilizing Nvidia's Jetson platform for edge computing and advanced sensor-fusion algorithms.

Saurabh Chandra, the CEO of Ati Motors, stated that the new funding will accelerate the development of next-generation AI models and enhance their industrial autonomy platform.